Skip to main content
. 2021 Mar 19;11:179. doi: 10.1038/s41398-021-01287-w

Fig. 4. Phenotypic characterization of CB-iMGs derived from CB-MNCs exposed to maternal SARS-CoV-2 infection.

Fig. 4

a Phase contrast ramified morphology of patient-derived CB-iMGs. Scale bar: 30 μm. b Immunostained images of exposed CB-iMG cells with nuclei (Hoechst) and indicated microglial markers (i) IBA1, (ii) CX3CR1, (iii) P2RY12, and (iv) PU.1. Scale bar: 25 μm.